Financials

  • Market Capitalization 8.09 B
  • Employee 3 100
  • Founded 1976
  • CEO Charles R. Kummeth
  • Website www.bio-techne.com
  • Headquarter Minnesota, United States
  • FIGI BBG000C15114
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
75.74
Price to sales ratio
6.8
Dividends per share
0.08
Dividend yield %
1.07

Bio-Techne Corp - Common Stock

Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.

News